Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy-Reference-Cited by-同舟云学术

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

Published:2013-02-20 Issue:4 Volume:27 Page:635-643
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Lacombe Jean-Marc,Boue François,Grabar Sophie,Viget Nathalie,Gazaignes Sandrine,Lascaux-Cametz Anne-Sophie,Pacanowski Jérome,Partisani Marialuisa,Launay Odile,Matheron Sophie,Rosenthal Eric,Rouveix Elisabeth,Tattevin Pierre,de Truchis Pierre,Costagliola Dominique,Goedert James J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference29 articles.

1. Immune restoration disease after antiretroviral therapy.;French;AIDS,2004

2. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.;Muller;Lancet Infect Dis,2010

3. Recrudescent Kaposis sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.;Leidner;AIDS Patient Care STDS,2005

4. Immune reconstitution inflammatory syndrome associated with Kaposis sarcoma.;Bower;J Clin Oncol,2005

5. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.;Letang;J Acquir Immune Defic Syndr,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients;Clinical and Experimental Immunology;2023-10-31

2. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial;PLOS ONE;2023-05-17

3. Kaposi’s Sarcoma;European Handbook of Dermatological Treatments;2023

4. CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era;AJN, American Journal of Nursing;2022-12

5. Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients;Cancers;2022-01-14